Beyond Air, Inc. Fair Value Adjustment of Warrants
Beyond Air, Inc. (XAIR) reported Fair Value Adjustment of Warrants of -$1.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-13
- Beyond Air, Inc. fair value adjustment of warrants for the quarter ending 2026-06-30 was -$1.00K.
- Beyond Air, Inc. fair value adjustment of warrants for the quarter ending 2026-03-31 was $1.00K.
- Beyond Air, Inc. fair value adjustment of warrants for the quarter ending 2025-12-31 was -$20.00K.
- Beyond Air, Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was $1.00K, a 75.00% decline year-over-year.
- Beyond Air, Inc. fair value adjustment of warrants for fiscal 2026 was -$35.00K.
- Beyond Air, Inc. fair value adjustment of warrants for fiscal 2025 was -$237.00K.
- Beyond Air, Inc. fair value adjustment of warrants for fiscal 2024 was -$611.00K.
- Beyond Air, Inc. fair value adjustment of warrants for fiscal 2017 was $2.43M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.00K 10-Q · filed 2026-08-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | -$20.00K derived: sum of 3 quarters · filed 2026-08-13 | -$19.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26 | -$19.00K derived: sum of 2 quarters · filed 2026-06-26 | -$18.00K derived: sum of 3 quarters · filed 2026-06-26 | -$35.00K 10-K · filed 2026-06-26 |
| 2025-12-31 | -$20.00K 10-Q · filed 2026-02-13 | -$19.00K derived: sum of 2 quarters · filed 2026-02-13 | -$36.00K 10-Q · filed 2026-02-13 | -$54.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | $1.00K 10-Q · filed 2025-11-10 | -$16.00K 10-Q · filed 2025-11-10 | -$34.00K derived: sum of 3 quarters · filed 2026-08-13 | -$38.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$17.00K 10-Q · filed 2026-08-13 | -$35.00K derived: sum of 2 quarters · filed 2026-08-13 | -$39.00K derived: sum of 3 quarters · filed 2026-08-13 | -$35.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26 | -$22.00K derived: sum of 2 quarters · filed 2026-06-26 | -$18.00K derived: sum of 3 quarters · filed 2026-06-26 | -$237.00K 10-K · filed 2026-06-26 |
| 2024-12-31 | -$4.00K 10-Q · filed 2026-02-13 | $0.00 derived: sum of 2 quarters · filed 2026-02-13 | -$219.00K 10-Q · filed 2026-02-13 | -$137.00K derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-09-30 | $4.00K 10-Q · filed 2025-11-10 | -$214.00K 10-Q · filed 2025-11-10 | -$133.00K derived: sum of 3 quarters · filed 2025-11-10 | -$179.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$219.00K 10-Q · filed 2025-08-12 | -$137.00K derived: sum of 2 quarters · filed 2025-08-12 | -$183.00K derived: sum of 3 quarters · filed 2025-08-12 | -$507.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-20 | $36.00K derived: sum of 2 quarters · filed 2025-06-20 | -$288.00K derived: sum of 3 quarters · filed 2025-06-20 | -$611.00K 10-K · filed 2025-06-20 |
| 2023-12-31 | -$46.00K 10-Q · filed 2025-02-10 | -$370.00K derived: sum of 2 quarters · filed 2025-02-10 | -$693.00K 10-Q · filed 2025-02-10 | |
| 2023-09-30 | -$324.00K 10-Q · filed 2024-11-12 | -$647.00K 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | -$324.00K 10-Q · filed 2024-08-06 | |||
| 2018-09-30 | $3.35M 10-Q · filed 2018-11-14 | |||
| 2017-12-31 | $2.43M 10-KT · filed 2018-06-15 | |||
| 2017-09-30 | $4.93M 10-Q · filed 2018-11-14 | |||
| 2017-03-31 | $2.43M 10-KT · filed 2018-06-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |